Previous Article | Next Article ![]()
Journal of Bacteriology, March 2001, p. 1694-1706, Vol. 183, No. 5
Schering-Plough Research Institute,
Kenilworth, New Jersey 07033,1 and
Genome Therapeutics Corporation, Waltham, Massachusetts
024532
Received 22 September 2000/Accepted 7 December 2000
In vivo genetic footprinting was developed in the yeast
Saccharomyces cerevisiae to simultaneously assess the
importance of thousands of genes for the fitness of the cell under any
growth condition. We have developed in vivo genetic footprinting for Escherichia coli, a model bacterium and pathogen. We
further demonstrate the utility of this technology for rapidly
discovering genes that affect the fitness of E. coli under
a variety of growth conditions. The definitive features of this system
include a conditionally regulated Tn10 transposase with
relaxed sequence specificity and a conditionally regulated replicon for
the vector containing the transposase and mini-Tn10
transposon with an outwardly oriented promoter. This system results in
a high frequency of randomly distributed transposon insertions,
eliminating the need for the selection of a population containing
transposon insertions, stringent suppression of transposon mutagenesis,
and few polar effects. Successful footprints have been achieved for
most genes longer than 400 bp, including genes located in operons. In
addition, the ability of recombinant proteins to complement mutagenized hosts has been evaluated by genetic footprinting using a bacteriophage
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.5.1694-1706.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Genetic Footprinting in Bacteria

transposon delivery system.
*
Corresponding author. Mailing address:
Schering-Plough Research Institute, 2015 Galloping Hill
Road (4700), Kenilworth, NJ 07033-0539. Phone: (908) 740-7597. Fax: (908) 740-3918. E-mail: scott.walker{at}spcorp.com.
This article is dedicated to the memory of Claire M. Berg, who
advised us on the early stages of this project and was a dear mentor
and friend.
Present address: Millennium Pharmaceuticals, Inc., 75 Sidney
St., Cambridge, MA 02139.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |